Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Recruiting
Observational Study
Venous Embolism of Lower Extremities (Diagnosis)
Arterial Embolism and Thrombosis
Acute DVT of Lower Extremity
Chronic DVT of Lower Extremity
DVT
Deep Vein Thrombosis Leg
Thrombus in the Peripheral Venous Vasculature
Peripheral Arterial Disease
Acute Limb Ischemia
Lower Extremity Acute Limb Ischemia
LE ALI
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 22 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- Medtronic Endovascular · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Patient case selection to be included in the clinical assessment will be specific to Liberant and will be made according to the following criteria:
1. Patient treated is age ≥ 22 years at the time of procedure
2. Use of Liberant in accordance with the device labeling within 72 hours of index proced…
Contacts